Contineum Therapeutics(CTNM)
SAN DIEGO, CA
BiotechnologyFocus: Small Molecule for MS
Contineum Therapeutics is a life sciences company focused on Small Molecule for MS.
NeurologyRespiratory
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
PIPE-307
Multiple SclerosisClinical Trials (1)
NCT04725175Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers
Phase 1PIPE-791
Chronic Osteoarthritis PainClinical Trials (1)
NCT06810245Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain
Phase 1PIPE-791
Multiple SclerosisClinical Trials (1)
NCT05983939Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers
Phase 1Phase 1
Clinical Trials (1)
NCT06683612PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF
Phase 1PIPE-307
Multiple SclerosisClinical Trials (1)
NCT04941781PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers
Phase 1PIPE-505
Sensorineural Hearing LossClinical Trials (1)
NCT04462198Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
Phase 1/2PIPE-307 Dose A
Relapsing Remitting Multiple SclerosisClinical Trials (1)
NCT06083753Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis
Phase 2PIPE-791 Dose A
Idiopathic Pulmonary FibrosisClinical Trials (1)
NCT07284459Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 8 clinical trials
SEC Filings: 2 available